Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.265.10 CHF
Change Today -1.30 / -0.49%
Volume 853.3K
As of 11:43 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by ROCHE HOLDING AG-GENUSSCHEIN (ROG) in the last 6 months

Announced 04/13/15
Capp Medical, Inc.

Roche Holding AG (SWX:ROG) acquired CAPP Medical on April 13, 2015.

ROG's price was unchanged after the transaction was announced on 04/13/15.
Investor / Buyer
Roche Holding AG
Announced 02/9/15
Signature Diagnostics AG

Roche Holding AG (SWX:ROG) acquired Signature Diagnostics AG from VRP Venture Capital Rheinland-Pfalz GmbH & Co. I managed by EVP Capital Management AG, KfW Mittelstandsbank, Investment Arm, IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, BC Brandenburg Capital GmbH and others on February 9, 2015. Signature will be integrated into Roche Sequencing Unit and will continue to focus on expanding its innovative genomic signature portfolio.

ROG's price was unchanged after the transaction was announced on 02/9/15.
Investor / Buyer
Roche Holding AG
Creditor / Lender
BC Brandenburg Capital GmbH
EVP Capital Management AG
GoodVent Beteiligungsmanagement GmbH & Co.KG
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH
IBG Risikokapitalfonds I GmbH & Co. KG
KfW Mittelstandsbank, Investment Arm
Announced 01/16/15
470.00M for Trophos SA

Roche Holding AG (SWX:ROG) entered into agreement to acquire Trophos SA from ACG Management, Turenne Capital Partenaires, Association Française contre les Myopathies, Vesale Partners, OTC Agregator, Amundi Private Equity Funds, Sofipaca SCR ans about sixty employees, relatives and the founders for €470 million on January 16, 2015. Under the terms of the agreement, Trophos's shareholders will receive an upfront cash payment of €120 million, plus additional contingent ...
Read More

ROG's price was unchanged after the transaction was announced on 01/16/15.
Investor / Buyer
Roche Holding AG
Creditor / Lender
ACG Management
Amundi Private Equity Funds
Association Française contre les Myopathies
OTC Agregator
Sofipaca SCR
Turenne Capital Partenaires
Vesale Partners

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROG:VX SFr.265.10 CHF -1.30

ROG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gilead Sciences Inc $115.04 USD -0.97
Merck & Co Inc $57.67 USD +0.07
Novartis AG SFr.93.05 CHF -0.85
Pfizer Inc $33.37 USD -0.32
Sanofi €88.18 EUR -0.90
View Industry Companies

Industry Analysis


Industry Average

Valuation ROG Industry Range
Price/Earnings 25.5x
Price/Sales 4.7x
Price/Book 12.0x
Price/Cash Flow 20.8x
TEV/Sales 3.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROCHE HOLDING AG-GENUSSCHEIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at